| ［1］ |
Ku mar A, Seghal N, Naidu PS, et al. Colchicines-induced neurotoxicity as an animal model of sporadic dementia of Alzheimer’s type[J].Pharmacol Rep,2007,59（3）:274-283.
|
| ［2］ |
Francis PT. Altered glutamate neurotransmission and behaviour in dementia: evidence from studies of memantine[J]. Curr Mol Pharmacol,2009,2（1）:77-82.
|
| ［3］ |
Daniëls V,Baekelandt V,Taymans JM.On the road to leucine-rich repeat kinase 2 signalling: evidence from cellular and in vivo studies[J].Neurosignals,2011,19（1）:1-15.
|
| ［4］ |
Schlatterer SD, Acker CM, Davies P. c-Abl in neurodegenerative disease[J].J Mol Neurosci,2011,45（3）:445-452.
|
| ［5］ |
Rudrabhatla P, Pant HC. Phosphorylation-specific peptidyl-prolyl isomerization of neuronal cytoskeletal proteins by Pin1: implications for therapeutics in neurodegeneration[J]. J Alzheimers Dis,2010,19（2）:389-403.
|
| ［6］ |
Godin JD, Humbert S. Int Mitotic spindle: focus on the function of huntingtin[J].J Biochem Cell Biol,2011,43（6）:852-856.
|
| ［7］ |
Chong ZZ,Shang YC,Zhang L,et al.Mammalian target of rapamycin:hitting the bull’s-eye for neurological disorders[J]. Oxid Med Cell Longev,2010,3（6）:374-391.
|
| ［8］ |
Ravikumar B,Vacher C,Berger Z,et al.Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease[J].Nat Genet,2004,36（6）:585-595.
|
| ［9］ |
Ravikumar B, Acevedo-Arozena A, Imarisio S, et al. Dynein mutations impair autophagic clearance of aggregate-prone proteins[J].Nat Genet,2005,37（7）:771-776.
|
| ［10］ |
Caviston JP, Holzbaur EL. Huntingtin as an essential integrator of intracellular vesicular trafficking[J].Trends Cell Biol,2009,19（4）:147-155.
|
| ［11］ |
Zhao Y,Fang WS,Pors K.Microtubule stabilising agents for cancer chemotherapy[J].Expert Opin Ther Pat,2009,19（5）:607-622.
|
| ［12］ |
Benitez-King G, Ramírez-Rodríguez G, Ortíz L, et al. The neuronal cytoskeleton as a potential therapeutical target in neurodegenerative diseases and schizophrenia[J].Curr Drug Targets CNS Neurol Disord,2004,3（6）:515-533.
|
| ［13］ |
Dean CE. Antipsychotic-associated neuronal changes in the brain:toxic, therapeutic, or irrelevant to the long-term outcome of schizophrenia ?[J]. Prog Neuropsychopharmacol Biol Psychiatry,2006,30（2）:174-189.
|
| ［14］ |
Brinijoin S, Koenigsberger C. Cholinesterases in neural development:new findings and toxicologic implications[J].Environ Health Perspect,1999,107（1）:59-64.
|
| ［15］ |
Benítez-King G.Melatonin as a cytoskeletal modulator:implications for cell physiology and disease[J].J Pineal Res,2006,40（1）:1-9.
|
| ［16］ |
Tanimukai H,Kudo T,Tanaka T,et al.Novel therapeutic strategies for neurodegenerative disease[J]. Psychogeriatrics, 2009, 9（2）:103-109.
|